Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion type Assertion NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_head.
- NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion description "[We have demonstrated that treatment with calcineurin inhibitors (CNIs) can induce the activation of proto-oncogenic Ras, and may promote a rapid progression of human renal cancer through the overexpression of vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_provenance.
- NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion evidence source_evidence_literature NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_provenance.
- NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion SIO_000772 21886838 NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_provenance.
- NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion wasDerivedFrom befree-20140225 NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_provenance.
- NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_assertion wasGeneratedBy ECO_0000203 NP493031.RAfZ8HS-Js30M52Bx-4lNZYeDfdmO0s3IA9yzpfZ26rLI130_provenance.